Policymaker, Please Consider Your Needs Carefully: Does Outcomes Research in Relapsed or Refractory Multiple Myeloma Reduce Policymaker Uncertainty Regarding Value for Money of Bortezomib?

M.G. Franken, J.G. Gaultney, H.M. Blommestein, P.C. Huijgens, P. Sonneveld, W.K. Redekop, C.A. Uyl-de Groot

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)245-253
JournalValue in Health
Volume17
Issue number2
DOIs
Publication statusPublished - 2014

Cite this

Franken, M.G. ; Gaultney, J.G. ; Blommestein, H.M. ; Huijgens, P.C. ; Sonneveld, P. ; Redekop, W.K. ; Uyl-de Groot, C.A. / Policymaker, Please Consider Your Needs Carefully: Does Outcomes Research in Relapsed or Refractory Multiple Myeloma Reduce Policymaker Uncertainty Regarding Value for Money of Bortezomib?. In: Value in Health. 2014 ; Vol. 17, No. 2. pp. 245-253.
@article{e9446beb647d4e84bbde75d2d086c078,
title = "Policymaker, Please Consider Your Needs Carefully: Does Outcomes Research in Relapsed or Refractory Multiple Myeloma Reduce Policymaker Uncertainty Regarding Value for Money of Bortezomib?",
author = "M.G. Franken and J.G. Gaultney and H.M. Blommestein and P.C. Huijgens and P. Sonneveld and W.K. Redekop and {Uyl-de Groot}, C.A.",
year = "2014",
doi = "10.1016/j.jval.2013.12.009",
language = "Undefined/Unknown",
volume = "17",
pages = "245--253",
journal = "Value in Health",
issn = "1098-3015",
publisher = "Elsevier Limited",
number = "2",

}

Policymaker, Please Consider Your Needs Carefully: Does Outcomes Research in Relapsed or Refractory Multiple Myeloma Reduce Policymaker Uncertainty Regarding Value for Money of Bortezomib? / Franken, M.G.; Gaultney, J.G.; Blommestein, H.M.; Huijgens, P.C.; Sonneveld, P.; Redekop, W.K.; Uyl-de Groot, C.A.

In: Value in Health, Vol. 17, No. 2, 2014, p. 245-253.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Policymaker, Please Consider Your Needs Carefully: Does Outcomes Research in Relapsed or Refractory Multiple Myeloma Reduce Policymaker Uncertainty Regarding Value for Money of Bortezomib?

AU - Franken, M.G.

AU - Gaultney, J.G.

AU - Blommestein, H.M.

AU - Huijgens, P.C.

AU - Sonneveld, P.

AU - Redekop, W.K.

AU - Uyl-de Groot, C.A.

PY - 2014

Y1 - 2014

U2 - 10.1016/j.jval.2013.12.009

DO - 10.1016/j.jval.2013.12.009

M3 - Article

VL - 17

SP - 245

EP - 253

JO - Value in Health

JF - Value in Health

SN - 1098-3015

IS - 2

ER -